Maximus, Inc. (NYSE:MMS) Position Lifted by Fuller & Thaler Asset Management Inc.

Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 7.4% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,234,933 shares of the health services provider's stock after buying an additional 84,835 shares during the period. Fuller & Thaler Asset Management Inc. owned approximately 2.16% of Maximus worth $92,188,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the business. UMB Bank n.a. boosted its position in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares in the last quarter. V Square Quantitative Management LLC boosted its position in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares in the last quarter. Hillsdale Investment Management Inc. boosted its position in shares of Maximus by 0.4% in the 4th quarter. Hillsdale Investment Management Inc. now owns 52,400 shares of the health services provider's stock worth $3,912,000 after buying an additional 230 shares in the last quarter. Bridge City Capital LLC grew its stake in Maximus by 0.9% in the 4th quarter. Bridge City Capital LLC now owns 28,503 shares of the health services provider's stock valued at $2,128,000 after acquiring an additional 254 shares during the last quarter. Finally, Inspire Advisors LLC increased its holdings in Maximus by 3.1% during the 4th quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider's stock valued at $646,000 after acquiring an additional 258 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.

Insider Activity

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at $171,167.68. This trade represents a 85.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company's stock.

Analyst Ratings Changes

Several analysts have recently commented on MMS shares. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James upgraded Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 target price on the stock in a report on Thursday, January 2nd.

Maximus Price Performance

Maximus stock traded down $1.26 during midday trading on Monday, reaching $66.46. 135,824 shares of the company were exchanged, compared to its average volume of 552,019. The company has a market capitalization of $3.76 billion, a price-to-earnings ratio of 14.29 and a beta of 0.68. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The firm's 50-day simple moving average is $67.65 and its 200-day simple moving average is $74.40. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts' consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. On average, analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio is currently 25.81%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.